Disseminated tuberculosis in a child during the COVID-19 pandemic: a case report and literature review

BackgroundDisseminated tuberculosis is an uncommon but devastating form of tuberculosis, possibly developing with the immune response of patients. COVID-19 infection may produce an immunosuppressive effect with possible implications for tuberculosis dissemination.Case presentationA 17-year-old femal...

Full description

Bibliographic Details
Main Authors: Taoping Weng, Yaqiong Dong, Niwen Huang, Chenqu Zhao, Lei Zhang, Shan Cao, Jing Tang, Danni Zhang, Xianming Zhang
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-09-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2023.1249878/full
_version_ 1797685955950280704
author Taoping Weng
Yaqiong Dong
Niwen Huang
Chenqu Zhao
Lei Zhang
Shan Cao
Jing Tang
Danni Zhang
Xianming Zhang
author_facet Taoping Weng
Yaqiong Dong
Niwen Huang
Chenqu Zhao
Lei Zhang
Shan Cao
Jing Tang
Danni Zhang
Xianming Zhang
author_sort Taoping Weng
collection DOAJ
description BackgroundDisseminated tuberculosis is an uncommon but devastating form of tuberculosis, possibly developing with the immune response of patients. COVID-19 infection may produce an immunosuppressive effect with possible implications for tuberculosis dissemination.Case presentationA 17-year-old female patient with a history of tuberculous pleurisy presented to the hospital with a high fever and life-threatening dyspnea after contracting a COVID-19 infection. Her condition deteriorated rapidly with grand mal epilepsy and acute gastrointestinal bleeding with a grossly depressed CD4 T-cell count, which was indicative of her profoundly immunosuppressed state. After identifying Mycobacterium tuberculosis in her cerebrospinal fluid and a subcutaneous abscess in her left lower back, she was diagnosed with disseminated tuberculosis involving both lungs, the central nervous system, the terminal ileum, the liver, bilateral adnexal tissue, and subcutaneous soft tissue in accordance with the chest and abdominal CT. Empirical treatment was initiated with dexamethasone (5 mg/day) and an anti-tuberculosis regimen of isoniazid, rifampicin, pyrazinamide, amikacin, and meropenem, which was replaced with faropenem after she left the hospital. The therapeutic effect was considered satisfied in the second month of follow-up.ConclusionTo the best of our knowledge, we report the first case report of disseminated tuberculosis after COVID-19 infection. Tuberculosis may disseminate and progress during the COVID-19 pandemic, requiring more significant studies to provide better diagnosis and treatment options for the co-infection.
first_indexed 2024-03-12T00:58:42Z
format Article
id doaj.art-025d6b6f3d3c4f9290ee7b25f4a9486c
institution Directory Open Access Journal
issn 1664-3224
language English
last_indexed 2024-03-12T00:58:42Z
publishDate 2023-09-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj.art-025d6b6f3d3c4f9290ee7b25f4a9486c2023-09-14T09:21:36ZengFrontiers Media S.A.Frontiers in Immunology1664-32242023-09-011410.3389/fimmu.2023.12498781249878Disseminated tuberculosis in a child during the COVID-19 pandemic: a case report and literature reviewTaoping WengYaqiong DongNiwen HuangChenqu ZhaoLei ZhangShan CaoJing TangDanni ZhangXianming ZhangBackgroundDisseminated tuberculosis is an uncommon but devastating form of tuberculosis, possibly developing with the immune response of patients. COVID-19 infection may produce an immunosuppressive effect with possible implications for tuberculosis dissemination.Case presentationA 17-year-old female patient with a history of tuberculous pleurisy presented to the hospital with a high fever and life-threatening dyspnea after contracting a COVID-19 infection. Her condition deteriorated rapidly with grand mal epilepsy and acute gastrointestinal bleeding with a grossly depressed CD4 T-cell count, which was indicative of her profoundly immunosuppressed state. After identifying Mycobacterium tuberculosis in her cerebrospinal fluid and a subcutaneous abscess in her left lower back, she was diagnosed with disseminated tuberculosis involving both lungs, the central nervous system, the terminal ileum, the liver, bilateral adnexal tissue, and subcutaneous soft tissue in accordance with the chest and abdominal CT. Empirical treatment was initiated with dexamethasone (5 mg/day) and an anti-tuberculosis regimen of isoniazid, rifampicin, pyrazinamide, amikacin, and meropenem, which was replaced with faropenem after she left the hospital. The therapeutic effect was considered satisfied in the second month of follow-up.ConclusionTo the best of our knowledge, we report the first case report of disseminated tuberculosis after COVID-19 infection. Tuberculosis may disseminate and progress during the COVID-19 pandemic, requiring more significant studies to provide better diagnosis and treatment options for the co-infection.https://www.frontiersin.org/articles/10.3389/fimmu.2023.1249878/fulltuberculosisdisseminated tuberculosisCOVID-19immunosuppressiontreatmentcase report
spellingShingle Taoping Weng
Yaqiong Dong
Niwen Huang
Chenqu Zhao
Lei Zhang
Shan Cao
Jing Tang
Danni Zhang
Xianming Zhang
Disseminated tuberculosis in a child during the COVID-19 pandemic: a case report and literature review
Frontiers in Immunology
tuberculosis
disseminated tuberculosis
COVID-19
immunosuppression
treatment
case report
title Disseminated tuberculosis in a child during the COVID-19 pandemic: a case report and literature review
title_full Disseminated tuberculosis in a child during the COVID-19 pandemic: a case report and literature review
title_fullStr Disseminated tuberculosis in a child during the COVID-19 pandemic: a case report and literature review
title_full_unstemmed Disseminated tuberculosis in a child during the COVID-19 pandemic: a case report and literature review
title_short Disseminated tuberculosis in a child during the COVID-19 pandemic: a case report and literature review
title_sort disseminated tuberculosis in a child during the covid 19 pandemic a case report and literature review
topic tuberculosis
disseminated tuberculosis
COVID-19
immunosuppression
treatment
case report
url https://www.frontiersin.org/articles/10.3389/fimmu.2023.1249878/full
work_keys_str_mv AT taopingweng disseminatedtuberculosisinachildduringthecovid19pandemicacasereportandliteraturereview
AT yaqiongdong disseminatedtuberculosisinachildduringthecovid19pandemicacasereportandliteraturereview
AT niwenhuang disseminatedtuberculosisinachildduringthecovid19pandemicacasereportandliteraturereview
AT chenquzhao disseminatedtuberculosisinachildduringthecovid19pandemicacasereportandliteraturereview
AT leizhang disseminatedtuberculosisinachildduringthecovid19pandemicacasereportandliteraturereview
AT shancao disseminatedtuberculosisinachildduringthecovid19pandemicacasereportandliteraturereview
AT jingtang disseminatedtuberculosisinachildduringthecovid19pandemicacasereportandliteraturereview
AT dannizhang disseminatedtuberculosisinachildduringthecovid19pandemicacasereportandliteraturereview
AT xianmingzhang disseminatedtuberculosisinachildduringthecovid19pandemicacasereportandliteraturereview